ウリナスタチン膣坐剤の製剤化およびその品質評価
スポンサーリンク
概要
- 論文の詳細を見る
Hospitals prepare ulinastatin vaginal suppositories for use in the treatment of threatened abortion.As it is important to ensure that suppositories are uniform,we developed an analytical procedure for ulinastatin in the suppository and examined the suitability of the preparation procedure.We could successfully use the spectroscopical analysis procedure for ulinastatin described in JP XIV when the suppository base was removed from the mixture after the color reaction with trypsin,but not when it was removed before.The reproducibility and accuracy of our analytical procedure were very good.The preparation of the ulinastatin suppository from its injection was found to require careful control of the water loss from the mixture.When this was done,ulinastatin content in the suppository was the same as in the original injection,and the content uniformity was good.Testing for change in ulinastatin content and microbial growth during the storage of suppositories in a refrigerator for 3-months produced satisfactory results.In conclusion,the method for the preparation of this drug from the injection and that for the analysis of the ulinastatin in the suppository that we developed should be useful to hospitals.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)